ASO Author Reflections: The Multidisciplinary Approach to de Novo Metastatic Inflammatory Breast Cancer: A Combined Systemic and Locoregional Strategy

Lauren M Postlewait^{1

2}, Anthony Lucci^{3

4}

Affiliations

¹ Department of Breast Surgical Oncology, Division of Surgery, University of Texas MD Anderson Cancer Center, 1400 Pressler Street, Unit 1434, Houston, TX, USA.
² Division of Surgical Oncology, Department of Surgery, Emory University, Atlanta, GA, USA.
³ Department of Breast Surgical Oncology, Division of Surgery, University of Texas MD Anderson Cancer Center, 1400 Pressler Street, Unit 1434, Houston, TX, USA. alucci@mdanderson.org.
⁴ Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, University of Texas MD Anderson Cancer Center, Houston, TX, USA. alucci@mdanderson.org.

Lauren M Postlewait et al. Ann Surg Oncol. 2021 Aug.

. 2021 Aug;28(8):4275-4276.

doi: 10.1245/s10434-020-09421-6. Epub 2021 Jan 6.

Lauren M Postlewait^{1

2}, Anthony Lucci^{3

4}

¹ Department of Breast Surgical Oncology, Division of Surgery, University of Texas MD Anderson Cancer Center, 1400 Pressler Street, Unit 1434, Houston, TX, USA.
² Division of Surgical Oncology, Department of Surgery, Emory University, Atlanta, GA, USA.
³ Department of Breast Surgical Oncology, Division of Surgery, University of Texas MD Anderson Cancer Center, 1400 Pressler Street, Unit 1434, Houston, TX, USA. alucci@mdanderson.org.
⁴ Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, University of Texas MD Anderson Cancer Center, Houston, TX, USA. alucci@mdanderson.org.

No abstract available

References

1. Soran A, Ozmen V, Ozbas S, et al. Randomized trial comparing resection of primary tumor with no surgery in stage IV breast cancer at presentation: protocol MF07-01. Ann Surg Oncol. 2018;25:3141–9. - DOI
1. Badwe R, Gupta S, Nair N, Parmar V, Hawaldar R. Survival of patients with metastatic breast cancer with or without locoregional therapy: authors’ reply. Lancet Oncol. 2015;16:e587–8. - DOI
1. Khan SA, Zhao F, Solin LJ, Goldstein LJ, Cella D, Basik M, et al. A randomized phase III trial of systemic therapy plus early local therapy versus systemic therapy alone in women with de novo stage IV breast cancer: a trial of the ECOG-ACRIN Research Group (E2108). J Clin Oncol. 2020. https://doi.org/10.1200/jco.2020.38.18_suppl.lba2 . - DOI - PubMed
1. Weiss A, Menen RS, Lin HY, et al. Factors associated with improved outcomes for metastatic inflammatory breast cancer patients. Breast Cancer Res Treat. 2018;169:615–23. - DOI
1. Akay CL, Ueno NT, Chisholm GB, et al. Primary tumor resection as a component of multimodality treatment may improve local control and survival in patients with stage IV inflammatory breast cancer. Cancer. 2014;120:1319–28. - DOI